3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
7
Unknown
4
Terminated
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Keratosis, Actinic
3
Uterine Cervical Dysplasia
2
Glioblastoma
2
Pigmentation Disorders
1
Neoplasms
1
Melanoma
1
Hemangioma, Capillary
1
Glioma
1
Ependymoma
1
Diffuse Intrinsic Pontine Glioma
1
Breast Neoplasms
1
Brain Neoplasms
1
Atypical Squamous Cells of the Cervix
1
Interventions
Imiquimod
2
Flow Cytometry
2
Colposcopy
2
Biopsy
2
motexafin lutetium
1
Zoledronic Acid
1
Surveys and Questionnaires
1
Spectrometry, Fluorescence
1
Sodium Chloride
1
Quantitative Phase Imaging
1
Photochemotherapy
1
Omeprazole
1
Mutagenesis, Insertional
1
Multimodal Imaging
1
Microarray Analysis
1
Indomethacin
1
Immunohistochemistry
1
IRX 2
1
Geritol
1
Fluorescent Antibody Technique
1
Cyclophosphamide
1
Cryosurgery
1
Conization
1
5-aminolevulinic acid hexyl ester
1
1-phenyl-3,3-dimethyltriazene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Uterine Cervical Dysplasia
×
Imiquimod
×
Clear all
NCT02329171
2018-08-15
TOPIC
Maastricht University Medical Center
Phase 3
Terminated
9 enrolled
NCT01283763
2016-11-01
ITIC2
Medical University of Vienna
Phase 3
Terminated
95 enrolled